International Clinical Trial: Study on the Safety and Efficacy of Cilostazol Combined with Aspirin in Patients with Ischemic Stroke

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124909) titled 'Study on the Safety and Efficacy of Cilostazol Combined with Aspirin in Patients with Ischemic Stroke' on May 19.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Drum Tower Hospital

Condition: Acute Ischemic Stroke

Intervention: Clopidogrel Group:Clopidogrel plus Aspirin

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-03-22

Target Sample Size: Clopidogrel Group:229;Cilostazol Group:229;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=315369

Disclaimer: Curated by HT Syndication....